Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof

A trichomonal vaginitis and composition technology, applied in the direction of drug combination, pharmaceutical formula, hydroxyl compound active ingredients, etc., can solve the problem of inability to achieve anti-inflammatory and antipruritic effects, unsatisfactory therapeutic effect, unsatisfactory curative effect, etc. problems, to achieve good social value and economic benefits, convenient administration, and rapid antipruritic effects

Inactive Publication Date: 2011-09-14
王连芝
View PDF7 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The effect of antibiotics in treating various genitourinary system inflammations and dysmenorrhea in gynecology is very unsatisfactory. Treating such gynecological diseases with western medicine not only has poor curative effect and easy recurrence, but also has large side effects, and there is no special Chinese patent medicine
Clinically, traditional Chinese medicine doctors take decoctions orally with foreign prescriptions according to the disease syndrome, and some traditional Chinese medicine lotion

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof
  • Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof
  • Chinese medicinal composition for treating trichomonas vaginitis and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0058] The preparation method of the honey refining pill for oral administration of the present invention is: take Radix Polygoni Multiflori 1000g, Angelica 1000g, Atractylodes macrocephala 1000g, Chinese yam 1000g, Astragalus 1000g, Jujube 1000g, Cuscuta 1000g, Millis Spatholobus 1000g, Mulberry 1000g, Alisma 1000g, Eclipta Grass 1000g, raspberry 1000g, rehmannia glutinosa 1000g, scutellaria baicalensis 1000g, paeonol 1000g; the raw material drug for oral administration is first pulverized into coarse powder, then further pulverized, and passed through a 100-120 mesh sieve to obtain a fine powder that can pass through the sieve When the amount reaches 30%, collect the fine powder that passes through the sieve to obtain fine powder a; then put the coarse powder that cannot pass through the 120 mesh sieve into a multi-functional extraction tank for extraction twice, add 10 times the amount of water for the first time and decoct for 1 hour, the second time Add 8 times the amount ...

experiment example 2

[0073] Experimental example 2: long-term toxicity test data

[0074] 1. Experimental method

[0075] The guinea pigs were randomly divided into 4 groups, 15 in each group. Apply the depilatory agent evenly on both sides of the back spine of the guinea pig, so that the range of depilation is about 40 square centimeters. Clean the depilatory agent, observe each group of guinea pigs after 24 hours to be coated with respectively 0.2,0.4 and 0.8ml of the present invention's orally administered traditional Chinese medicine preparation Honey Refined Pills, contain crude drug 92,184 and 368mg respectively, another group is coated with vehicle 0.8ml twice a day, For 30 consecutive days, the general condition of the guinea pigs was observed. After the experiment, the animals were sacrificed for hematology, blood biochemical and pathological examinations.

[0076] 2. Results

[0077] No edema, hyperemia, erythema, bleeding spots and ulcers were found in the depilated trunk area of ​​g...

experiment example 3

[0078] Experimental example 3: Cumulative toxicity test:

[0079] Traditional Chinese medicine preparation of the present invention is taken orally honey refined pills to mice by 7.69, 19.18 and 43.21g crude drug / kg continuous medication 15 weeks (1.0ml / 100g body weight, every day 2 times) and after drug withdrawal 3 weeks, the result shows: Chinese medicine of the present invention The preparation has no obvious effect on the hair, behavior, defecation, body weight, organ weight, blood picture, liver and kidney function, blood sugar, blood lipid and other indicators of rats. After 1 week and 3 weeks after stopping the drug, there was no significant change in the organs of the rats. It shows that the oral capsule of the traditional Chinese medicine preparation of the present invention has little toxicity to rats after long-term administration, and there is no abnormal reaction after drug withdrawal, so the application is safe.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Chinese medicinal composition for treating trichomonas vaginitis, wherein medicines for oral use comprise: 10-20 parts of prepared fleeceflower root, 10-20 parts of angelica sinensis, 10-20 parts of white atractylodes rhizome, 10-20 parts of Chinese yam, 10-20 parts of radix astragali, 10-20 parts of Chinese date, 10-20 parts of dodder, 10-20 parts of caulis spatholobi, 10-20 parts of mulberry, 10-20 parts of rhizoma alismatis, 10-20 parts of eclipta alba, 10-20 parts of raspberry, 10-20 parts of prepared rehmannia root, 10-20 parts of radix scutellariae and 10-20 parts of cortex moutan; and medicines for external use comprise: 10-30 parts of phellodendron amurense, 10-30 parts of radix sophorae flavescentis, 10-30 parts of common cnidium fruit, 10-30 parts of natural indigo, 10-30 parts of folium artemisiae argyi, 10-30 parts of radix stemonae, 10-30 parts of sargentgloryvine stem, 10-30 parts of caulis spatholobi, 10-30 parts of pricklyash peel, 10-30 parts of smoked plum, 10-30 parts of broom cypress fruit, 10-30 parts of borneol and 10-30 parts of purslane. The Chinese medicinal composition for treating trichomonas vaginitis, disclosed by the invention, has the advantages of fastness in itching relieving, strong antiphlogosis and antibacterium property, convenience for drug administration, easiness in medicament manufacture, low cost and the like.

Description

technical field [0001] The invention relates to a medical preparation containing components derived from plants, animals or minerals, in particular to a traditional Chinese medicine composition for treating trichomonal vaginitis and a preparation method thereof. Background technique [0002] Vaginitis is a kind of gynecological common disease, frequently-occurring disease, often perplexes many women, and severe case can influence patient's study, work and the whole life of women. The main clinical manifestations are fungal vaginitis, trichomonal vaginitis, and bacterial vaginosis. This disease belongs to the category of leukorrhagia and pruritus vulvae in traditional Chinese medicine. The main clinical manifestations are excessive leukorrhea, abnormal changes in color and quality. Trichomonas vaginitis is a common vaginitis caused by Trichomonas vaginalis. Clinically, the main manifestations are increased leucorrhea, rare foam, foul smell, and vaginal itching. The onset ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8945A61K36/904A61K9/02A61K9/14A61K9/20A61K47/14A61K47/34A61K47/44A61P15/02A61P33/02A61K31/045
Inventor 王连芝
Owner 王连芝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products